Virus-like particles production in green plants.
Viruses-like particles (VLPs), assembled from capsid structural subunits of several different viruses, have found a number of biomedical applications such as vaccines and novel delivery systems for nucleic acids and small molecules. Production of recombinant proteins in different plant systems has been intensely investigated and improved upon in the last two decades. Plant-derived antibodies, vaccines, and microbicides have received great attention and shown immense promise. In the case of mucosal vaccines, orally delivered plant-produced VLPs require minimal processing of the plant tissue, thus offering an inexpensive and safe alternative to more conventional live attenuated and killed virus vaccines. For other applications which require higher level of purification, recent progress in expression levels using plant viral vectors have shown that plants can compete with traditional fermentation systems. In this review, the different methods used in the production of VLPs in green plants are described. Specific examples of expression, assembly, and immunogenicity of several plant-derived VLPs are presented.
Santi
Luca
L
Biodesign Institute at Arizona State University, Tempe, 852878-5401, USA.
Huang
Zhong
Z
Mason
Hugh
H
D001709:Biotechnology / Q000379:methods*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D006511:Hepatitis B Antigens / Q000276:immunology; D009663:Norwalk virus / Q000276:immunology; D030821:Plants, Genetically Modified / Q000235:genetics / Q000378:metabolism*; D022701:Virosomes / Q000096:biosynthesis*
D006511:Hepatitis B Antigens; D022701:Virosomes